Cell Based Assays and Compound Screening

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Cell Based Assays

Compound Screening

[Panel Webinar] How to tap into pharma’s $100bn digital transformation opportunity

The Pharma Data

JANUARY 6, 2021

The pharma industry is witnessing a steep rise in the use of AI-driven solutions in early-stage drug discovery, deep-learning technologies for compound screening, and lead identification and automation enhancements in the lab. Next-generation digital technologies are having an immense impact on the drug discovery process.

Cell Based Assays

Cell Based Assays Compound Screening Organic Chemistry DNA

ChEMBL 34 is out!

The ChEMBL-og

APRIL 16, 2024

University of Dundee: T. 1813 bioactivities in total have been added.

Clinical Trials

Clinical Trials FDA Cell Based Assays Packaging

Re-assessing the risks of drug-induced arrhythmias during drug discovery

Drug Discovery World

AUGUST 15, 2023

However, many other drugs exhibit a more complex multichannel pharmacology 7 , which is much harder to interpret and cannot be easily modelled by screening against a single ion channel.

Drugs

Drugs Clinical Pharmacology Disease Engineering

Drug Discovery Digest

[Panel Webinar] How to tap into pharma’s $100bn digital transformation opportunity

ChEMBL 34 is out!

Re-assessing the risks of drug-induced arrhythmias during drug discovery

Stay Connected